Michael E. Ernst, Pharm.D., FCCP, BCGP (Director)

Dr. Ernst is a Clinical Professor in the Department of Pharmacy Practice and Science at the University of Iowa College of Pharmacy, and in the Department of Family Medicine, Carver College of Medicine, in Iowa City, IA.  He provides collaborative patient care in the Family Medicine clinic and the University of Iowa Geriatric Assessment Clinic, and is engaged in the interdisciplinary education of students from the UI Colleges of Pharmacy and Medicine, and medical residents and fellows in the Family Medicine residency program.  Dr. Ernst’s research is broadly focused in the area of medication use in older adults, and the treatment of hypertension and related cardiovascular risks, and is collaborative on local, national, and international levels.  He was an investigator in some of the earliest NHLBI-funded studies examining pharmacist-physician co-management of hypertension and has published extensively in the areas of ambulatory blood pressure monitoring, the comparative effects of thiazide diuretics, and the prognostic impact of long-term blood pressure variability. In large multicenter clinical trials, he is currently part of the core leadership team of the internationally-conducted ASPirin in Reducing Events in the Elderly (ASPREE) and ASPREE-eXTension (ASPREE-XT) studies which have been funded by NIA since 2010, and is an investigator in the Pragmatic Evaluation of events and Benefits of Lipid-lowering in older adults (PREVENTABLE) trial.  Dr. Ernst is a Board Certified Geriatric Pharmacist, and was one of the first pharmacists nationally to receive the Certified Hypertension Specialist designation.  He is a member of the Target:BP Advisory Board, on the editorial board for Current Hypertension Reports, and the Journal of the American College of Clinical Pharmacy, and a regular reviewer for multiple journals.  He has served on the former ACCP Research Institute Board of Trustees, and since 2020 has served as the director of the ACCP Research and Scholarship Academy. 

Gary L. Cochran, Pharm.D.

Gary L. Cochran is an associate professor at the University of Nebraska Medical Center (UNMC). He received a B.S. degree in business administration from the University of Nebraska in 1991, a Pharm.D. degree from UNMC in 1997, and an M.S. degree in epidemiology from the Harvard School of Public Health in 2004. He completed a pharmacy practice residency and a pharmacoeconomics and outcomes research fellowship at UNMC in 1998 and 2000, respectively.

Cochran’s research objective is to improve the safety and quality of rural health care through advancing and disseminating knowledge that will affect both clinical care and health policy. His current research evaluates the effectiveness of medication use systems and health information technologies to improve health care safety and quality.

Sandra L. Kane-Gill, Pharm.D., FCCP

Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP, is Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy in Pittsburgh, Pennsylvania. She has secondary appointments in the School of Medicine in the Clinical Translational Science Institute, Department of Critical Care Medicine and the Department of Biomedical Informatics. She also serves as Professor for the Center for Critical Care Nephrology and Center for Medical Machine Learning. In addition to her academic appointments, Dr. Kane-Gill is Critical Care Medication Safety Pharmacist at the University of Pittsburgh Medical Center in the Department of Pharmacy Dr. Kane-Gill’s is an NIH funded research whose interests focus on the assessment of clinical, economic and quality outcomes for critically ill patients. Her goal is build a pharmacovigilance program to identify effective approaches for the detection, prevention, and management of medication errors and adverse drug events as to improve quality of care and patient safety. She led several pharmacopidemiology evaluations that improved patient safety surveillance systems, prevented medication errors and adverse drug events (ADEs) and used health information technology (clinical decision support, telemedicine, simulation) to improve services

Jacqueline McLaughlin, Ph.D.

Jacqueline McLaughlin received her B.S. degree in biological engineering from North Carolina State University, her M.S. degree in biomedical engineering from the University of Memphis, and her Ph.D. degree in educational research and policy analysis from North Carolina State University. She spent 1 year as a postdoctoral fellow with the Office of Strategic Planning and Assessment (OSPA) at the UNC Eshelman School of Pharmacy and currently serves the school as an associate professor of educational innovation and research and as the director of CIPhER (Center for innovative Pharmacy Education Research). McLaughlin has published more than 100 peer-reviewed papers about higher education and the health professions. She leads educational research about and across the continuum of education, including admissions, classroom engagement, experiential learning, and extracurricular activities.

McLaughlin is involved in educational research that examines relationships between student characteristics, engagement, and performance during a curriculum. Her research experience and interests extend across the context of admissions, classroom engagement, experiential learning, and extracurricular activities.

Daniela Moga, Ph.D.

Dr. Moga is an Associate Professor of Pharmacy Practice and Science, and Epidemiology at University of Kentucky. She currently serves as Larry H. Spears Endowed Chair in Pharmacogenetics and Assistant Dean for Research in the College of Pharmacy. Dr. Moga's areas of interest include geriatric pharmacoepidemiology and health outcomes research. Currently, her focus is on evaluating the use and health effects of potentially inappropriate medications by older adults with multiple comorbid conditions. In addition, Dr. Moga's research aims at developing interventions to deprescribe inappropriate medications and optimize treatment in older adults. Dr.Moga currently serves as PI for a large study evaluating the effect of a patient-centered medication therapy management team intervention aiming to bolster cognitive reserve by increasing medication appropriateness in older adults, “INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE study

Margie E. Snyder, Pharm.D., MPH, FCCP

Dr. Margie E. Snyder is a Professor of Pharmacy Practice at the Purdue University College of Pharmacy. Dr. Snyder completed her Doctor of Pharmacy, PGY-1 community pharmacy residency, Master of Public Health, and community practice research fellowship at the University of Pittsburgh. Her scholarship is focused on community pharmacist practice advancement. Her expertise is in collaboration with practice-based research networks (PBRNs) and the application of qualitative and mixed-methods. She founded and directs a community pharmacy PBRN (Rx-SafeNet). Dr. Snyder has been almost continuously federally funded since 2010, first receiving a KL2 award from the Indiana Clinical and Translational Sciences Institute (CTSI), followed by K08, R21, and R18 awards from the Agency for Healthcare Research and Quality (AHRQ). Her total extramural funding support to date equals approximately $2.5 million as a Principal Investigator and she has published over 60 peer-reviewed journal articles. She is currently the Chair of the NIH Organization and Delivery of Health Services study section. She is also the Associate Director of the Indiana CTSI K12 program. Dr. Snyder has been active in ACCP for over 10 years and was recognized as a Fellow in 2017.

Diana M. Sobieraj, Pharm.D., FCCP

Diana M. Sobieraj is an Associate Professor in the Department of Pharmacy Practice. She earned her Doctor of Pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/University of Connecticut School of Pharmacy. Dr. Sobieraj’s scholarly interests focus on comparative effectiveness and health outcomes research where she has over 2.5 million dollars of funded research and more than 60 publications in the peer-reviewed literature, including journals such as JAMA, Annals of Internal Medicine and the Journal of the American Geriatrics Society. Her primary work is in systematic review and meta-analysis resulting in several publications that have served as the evidence base for clinical practice guideline development in the United States. Dr. Sobieraj’s research has been recognized and awarded the 2018 ACCP New Investigator Award and the 2019 ASHP Drug Research Literate Award. She is a preceptor in the UConn Health Outcomes Fellowship Program and for the PGY-1 Residency Program at Hartford Hospital where she serves as a research advisor and preceptor for an academic rotation. Diana also serves as a member of the UConn IRB.

Jeremy Thomas, Pharm.D.

Jeremy Thomas is an associate professor in the Department of Pharmacy Practice at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy. He has provided clinical services in various primary care clinics in Arkansas and previously in Tennessee. As faculty in the UAMS Center for Implementation Research, he has worked to integrate pharmacist services into primary care practices through research as well as partnering with the Arkansas Blue Cross Blue Shield Primary Care Department on its patient-centered medical home programs. His current research interests include telehealth-delivered clinical pharmacist services.